OncoTherapy strikes another alliance for pipeline vaccine
This article was originally published in Scrip
Executive Summary
Japan's OncoTherapy Science (OTS) has struck its third collaborative agreement in as many weeks, this time with Shionogi, which has licensed rights to OTS vaccines for ophthalmic disorders.